Option Care Health

OPCH

Market cap $4.94B

The Touchstone Small Company Fund underperformed its benchmark, the Russell 2000 Index, for the quarter ended September 30, 2025. Among the Fund's top-performing sectors in terms of adding value were Financials and Consumer Staples. From a factor perspective, the Fund's focus on profitable, liquid, and higher quality small cap stocks negatively impacted relative performance during the quarter.

Option Care Health, Inc. ( OPCH ) UBS Global Healthcare Conference 2025 November 11, 2025 3:30 PM EST Company Participants Meenal Sethna - Executive VP & CFO Nicole Maggio Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division Okay. We're ready to get going.

BANNOCKBURN, Ill., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: UBS Global Healthcare Conference, being held in Palm Beach, on Tuesday, November 11, 2025, at 3:30pm ET/2:30pm CT.

Option Care Health, Inc. ( OPCH ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Nicole Maggio - Senior VP, Controller & Principal Accounting Officer John Rademacher - CEO, President & Director Meenal Sethna - Executive VP & CFO Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Joanna Gajuk - BofA Securities, Research Division David MacDonald - Truist Securities, Inc., Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Lucas Romanski - TD Cowen, Research Division Constantine Davides - Citizens JMP Securities, LLC, Research Division Brian Tanquilut - Jefferies LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Presentation Operator Good day, and thank you for standing by.

Option Care (OPCH) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.41 per share a year ago.

BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025.

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?